Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational biotherapeutics consulting, is pleased to announce the acquisition of Bruder Consulting & Venture Group (“Bruder” or “BCVG”), a strategic advisory and consulting firm with a global footprint in biotech and biopharma, known for their expertise in the discovery, development, clinical design, and regulatory approval process of biologics, devices and combination products in the orthopedic, wound care, and plastic & reconstructive surgery markets. BCVG is now a department within Dark Horse Consulting (DHC) known as DHC Regenerative Medicine.
Read the full article: Bruder Consulting & Venture Group to Become Dark Horse Consulting Regenerative Medicine //
Source: https://www.globenewswire.com/news-release/2026/01/09/3216027/0/en/Bruder-Consulting-Venture-Group-to-become-Dark-Horse-Consulting-Regenerative-Medicine.html
